Dr .wenji Chen
Taiwan Liposome Company
Wenji Chen Ph.D., M.B.A. Vice President, Corporate Development Dr. Chen has served as our Vice President of Corporate Development since October 2016. Before joining TLC, Dr. Chen was the Vice President of Industrial Promotion at the Development Center of Biotechnology in Taiwan. Prior to that, Dr. Chen was Senior Director of Worldwide Business Development at GlaxoSmithKline R&D Co., Ltd. in Shanghai, China from 2010 to 2015. Dr. Chen served as Director of Worldwide Business Development at GlaxoSmithKline LLC in the Research Triangle Park facility in North Carolina from 2006 to 2010 and Business Development Director at Norak Biosciences Inc., a biotechnology firm, from 2002 to 2005. From 1992 to 2002, Dr. Chen was a principle investigator in the Research and Development Division of GlaxoSmithKline in the Research Triangle Park facility in North Carolina. Dr. Chen received a Ph.D. from the University of Texas Southwestern Medical Center, an M.B.A. from the University of North Carolina, Chapel Hill, and a B.S. from National Taiwan University, Taipei, Taiwan.
Pharma, Clinical research, Pharmaceutical sciences